Select Drug Profiles

Yihua Xu, PhD, Lavanya Sudharshan, MS, Ming-Ann Hsu, MPH, Andrew S. Koenig, DO, FACR, Joseph C. Cappelleri, PhD, Wen F. Liu, PharmD, BCPS, Timothy W. Smith, BA, Margaret K. Pasquale, PhD

Yihua Xu, PhD; Lavanya Sudharshan, MS; Ming-Ann Hsu, MPH; Andrew S. Koenig, DO, FACR; Joseph C. Cappelleri, PhD, MPH, MS; Wen F. Liu, PharmD, BCPS; Timothy W. Smith; Margaret K. Pasquale, PhD

Stakeholder Perspective

Engaging Patients in Decision-Making for Psoriatic Arthritis Treatment

F. Randy Vogenberg, PhD, RPh

by F. Randy Vogenberg, PhD, FASHP

Practice Management

FDA Commissioner Outlines New Plan to Increase Biosimilars by Balancing Innovation and Competition

Eileen Koutnik-Fotopoulos

Eileen Koutnik-Fotopoulos

Original Research

Treatment Tolerability in Patients with Immunoglobulin Light-Chain Amyloidosis

Avery A. Rizio, PhD, Michelle K. White, PhD, Kristen L. McCausland, MPH, PhD, Tiffany P. Quock, MS, PhD, Spencer D. Guthrie, MS, MBA, MPH, Miyo Yokota, PhD, Martha S. Bayliss, MS, MSc

Avery A. Rizio, PhD; Michelle K. White, PhD; Kristen L. McCausland, MPH, PhD; Tiffany P. Quock, MS, PhD; Spencer D. Guthrie, MS, MBA, MPH; Miyo Yokota, PhD; Martha S. Bayliss, MS, MSc

Perspectives

Unscaling Population Health

David B. Nash, MD, MBA